| 翻訳と辞書 |
| Ventana Medical Systems ： ウィキペディア英語版 |
Ventana Medical Systems
Ventana Medical Systems, Inc. is a global leader in tissue diagnostics. The company develops, manufactures, and markets instrument reagent systems that automate tissue and slide staining in anatomic pathology laboratories. These products assist in the diagnosis and treatment of cancer and infectious diseases.〔(【引用サイトリンク】 title=Ventana Medical Systems Inc )〕
Part of the Roche Diagnostics Division, Ventana is a member of the Roche Group.〔
==Company history==
Pathologist and University of Arizona professor Thomas Grogan, M.D., founded Ventana in 1985. The company launched its first instrument reagent system in 1991, and held an Initial Public Offering (IPO) in 1996, trading under the symbol VMSI on the NASDAQ stock exchange.〔(【引用サイトリンク】 title=Ventana Medical Systems )〕
In 2007, Ventana acquired Spring BioScience Corp, a developer and supplier of monoclonal antibodies. That same year, Ventana rejected a hostile takeover bid from Roche Holding AG for $75 a share.〔Doherty, Dermot (January 22, 2008). (Roche’s Higher Offer Wins Ventana After Seven Months (Update11) ). Bloomberg. Retrieved November 3, 2012.〕 In February 2008, Roche acquired Ventana with a cash offer of $89.50 per share ($3.4 billion).〔
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Ventana Medical Systems」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|